F. Leach

发表

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

Robin J. Leach, Paul S. Meltzer, Jean Weissenbach, 1993, Cell.

Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.

W. Linehan, Seong-Jin Kim, R. Morton, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Amplification of cyclin genes in colorectal carcinomas.

S. Elledge, K. Kinzler, B. Vogelstein, 1993, Cancer research.

Advances in Brief p 53 Mutation and MDM 2 Amplification in Human Soft Tissue Sarcomas 1

P. Meltzer, D. Hill, K. Kinzler, 2006 .

Sharpening the Tools for Prostate Cancer Detection in the PSA Era: What's the Point?

F. Leach, F. Leach, 2003, Cancer biology & therapy.

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.

Seong-Jin Kim, A. Remaley, Byung-Chul Kim, 2002, Cancer research.

Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events

A. Geballe, E. Mocarski, F. Leach, 1986, Journal of virology.

Regulation ofCytomegalovirus LateGeneExpression: -yGenesAre Controlled byPosttranscriptio nal Events

A. Geballe, E. Mocarski, F. Leach, 1986 .

Families Evaluable by Linkage

K. Kinzler, B. Vogelstein, L. Aaltonen, 2007 .

Regulation ofCytomegalovirus Late-Gene Expression: Differential UseofThreeStart Sites intheTranscriptional Activation of ICP36GeneExpression

E. Mocarski, F. Leach, 1989 .

Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression

E. Mocarski, F. Leach, 1989, Journal of virology.

Detection of mismatch repair gene expression in urologic malignancies.

F. Leach, 2003, Methods in molecular biology.

Clinicopathologic Implications of hMSH2 Gene Expression

P. Albert, A. Velasco, F. Leach, 2002 .

Molecular genetics of urothelial malignancies

F. Leach, 2001 .

p53 Mutation and MDM2 amplification in human soft tissue sarcomas.

P. Meltzer, K. Kinzler, B. Vogelstein, 1993, Cancer research.

Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence

P. Albert, A. Sagalowsky, S. Hewitt, 2002, Cancer.

Evaluation of the FHIT gene in colorectal cancers.

M. Wigler, K. Kinzler, B. Vogelstein, 1996, Cancer research.

Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with urothelial carcinoma of the bladder and adenocarcinoma of the prostate.

J. Ro, A. Ayala, J. Zhai, 2010, Archives of Pathology & Laboratory Medicine.

CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer

Michael Ittmann, Timothy C Thompson, M. Ittmann, 2006, Cancer biology & therapy.

Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.

B. Vogelstein, A. de la Chapelle, K. Polyak, 1996, Cancer research.

Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas.

L. Hedrick, K. Cho, H. Katabuchi, 1995, Cancer research.

Mismatch repair gene expression and genetic instability in testicular germ cell tumor

I. Wistuba, A. Berlin, M. Ittmann, 2004, Cancer biology & therapy.

Expression of the human mismatch repair gene hMSH2

A. Sagalowsky, M. Saboorian, J. Hsieh, 2000, Cancer.

Mismatch Repair Gene Mutations in Renal Cell Carcinoma

F. Leach, M. Koh, O. Elbahloul, 2002, Cancer biology & therapy.

Microsatellite instability and prostate cancer: clinical and pathological implications

F. Leach, 2002, Current opinion in urology.

Monoallelic mutation analysis (MAMA) for identifying germline mutations

K. Kinzler, B. Vogelstein, N. Papadopoulos, 1995, Nature Genetics.

Mismatch repair expression in testicular cancer predicts recurrence and survival

I. Wistuba, R. Chuaqui, A. Velasco, 2007 .

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.

F. Burkhard, U. Studer, A. Kappeler, 2005, The Journal of urology.

Targeting Prostate Specific Membrane Antigen in Cancer Therapy: Can Molecular Medicine Be Brought to the Surface?

F. Leach, 2004, Cancer biology & therapy.

[Immunohistochemical and molecular analyis of mismatch repair genes in germ cell tumors].

F. Leach, L. A. Villarroel del Pino, E. Riquelme Sanchez, 2005, Actas urologicas espanolas.

Detection of genetic loss in tumors by representational difference analysis.

M. Wigler, B. Vogelstein, B Vogelstein, 1994, Cold Spring Harbor symposia on quantitative biology.

Genetic mapping of a locus predisposing to human colorectal cancer.

J. Weber, B. Vogelstein, L. Aaltonen, 1993, Science.

Clues to the pathogenesis of familial colorectal cancer.

K. Kinzler, B. Vogelstein, L. Aaltonen, 1993, Science.

The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.

A. Sagalowsky, F. Leach, A. Velasco, 2000, The Journal of urology.

Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage.

A. Chapelle, K. Kinzler, B. Vogelstein, 1994, American journal of human genetics.

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.

Seong-Jin Kim, A. Remaley, D. Seong, 2002, Cancer research.